Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 15.10.2018 19 AIDS 2 AIDS Res Hum Retroviruses 1 Am J Epidemiol 3 Clin Infect Dis 1 HIV Med 5 J Acquir Immune Defic Syndr 1 J Immunol 8 J Infect Dis 4 J Virol 2 Lancet 5 Lancet HIV 2 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 2 N Engl J Med 1 Nature 1 Pediatr Infect Dis J 1 PLoS Med 16 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A 6 Science 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. ABRAMS EJ, Langwenya N, Gachuhi A, Zerbe A, et al
   Impact of universal ART for pregnant and postpartum women on ART uptake and retention.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002027.
   PubMed     Text format     Abstract available
   
   
2. FORD ES, Magaret AS, Spak CW, Selke S, et al
   Increase in HSV shedding at initiation of antiretroviral therapy (ART) and decrease in shedding over time on ART in HIV and HSV-2 infected persons.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002002.
   PubMed     Text format     Abstract available
   
   
3. SABIN CA, Harding R, Bagkeris E, Nkhoma K, et al
   Pain in people living with HIV and its association with healthcare resource use, well-being and functional status.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002021.
   PubMed     Text format     Abstract available
   
   
4. MARUTHAMUTHU S, Raja R, Pandian K, Madasamy S, et al
   Inhibitory NK cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002028.
   PubMed     Text format     Abstract available
   
   
5. CHOWDHURY FZ, Ouyang Z, Buzon M, Walker BD, et al
   Metabolic pathway activation distinguish transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002007.
   PubMed     Text format     Abstract available
   
   
6. VOURLI G, Pharris A, Cazein F, Costagliola D, et al
   Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002034.
   PubMed     Text format     Abstract available
   
   
7. LEAL L, Guardo AC, Moron-Lopez S, Salgado M, et al
   Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002026.
   PubMed     Text format     Abstract available
   
   
8. SUNDERMANN EE, Heaton RK, Pasipanodya E, Moore RC, et al
   Sex differences in HIV-associated cognitive impairment: an observational cohort study.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002012.
   PubMed     Text format     Abstract available
   
   
9. NYAMATHI AM, Carpenter CL, Ekstrand ML, Yadav K, et al
   Randomized controlled trial of a community-based intervention on HIV and nutritional outcomes at six months among women living with HIV/AIDS in Rural India.
   AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002016.
   PubMed     Text format     Abstract available
   
   
10. LOHMANN S, White BX, Zuo Z, Chan MS, et al
    HIV messaging on twitter: an analysis of current practice and data-driven recommendations.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002018.
    PubMed     Text format     Abstract available
    
    
11. DEBEAUDRAP P, Bodeau-Livinec F, Pasquier E, Germanaud D, et al
    Neurodevelopmental outcomes in HIV-infected and uninfected African children aged 4 to 9 years from the pediacam cohort.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002023.
    PubMed     Text format     Abstract available
    
    
12. ERICKSON M, Shannon K, Sernick A, Pick N, et al
    Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002036.
    PubMed     Text format     Abstract available
    
    
13. GALAVIZ KI, Schneider MF, Tien P, Mehta CC, et al
    Predicting diabetes risk among HIV-positive and HIV-negative women: an assessment of the ADA and FINRISC diabetes risk scores.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002017.
    PubMed     Text format     Abstract available
    
    
14. STONER MCD, Nguyen N, Kilburn K, Gomez-Olive FX, et al
    Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa: An HPTN 068 analysis.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002037.
    PubMed     Text format     Abstract available
    
    
15. MAJONGA ED, Rehman AM, Simms V, Mchugh G, et al
    High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002031.
    PubMed     Text format     Abstract available
    
    
16. SUDFELD CR, Buchanan A, Ulenga N, Spiegelman D, et al
    Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002033.
    PubMed     Text format     Abstract available
    
    
17. LAUT KG, Shepherd L, Gottfredsson M, Sedlacek D, et al
    Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002035.
    PubMed     Text format     Abstract available
    
    
18. ROUL H, Mary-Krause M, Ghosn J, Delaugerre C, et al
    CD4 cell count recovery after combined antiretroviral therapy in the modern cART era.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002010.
    PubMed     Text format     Abstract available
    
    
19. MCMILLAN J, Szlachetka A, Zhou T, Morsey B, et al
    Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002032.
    PubMed     Text format     Abstract available
    
    

    
    AIDS Res Hum Retroviruses

20. PAYNE H, Chain G, Adams S, Hunter P, et al
    Naive B-cell output in HIV-infected and HIV-uninfected children.
    AIDS Res Hum Retroviruses. 2018 Oct 9. doi: 10.1089/AID.2018.0170.
    PubMed     Text format     Abstract available
    
    
21. CURTIS AD, Walter K, Nabi R, Jensen K, et al
    Oral co-administration of an intramuscular DNA/ Modified Vaccinia Ankara vaccine for simian immunodeficiency virus is associated with better control of infection in orally exposed infant macaques.
    AIDS Res Hum Retroviruses. 2018 Oct 10. doi: 10.1089/AID.2018.0180.
    PubMed     Text format     Abstract available
    
    

    
    Am J Epidemiol

22. JENNESS SM, Maloney KM, Smith DK, Hoover KW, et al
    Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.
    Am J Epidemiol. 2018 Oct 11. pii: 5127085. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Clin Infect Dis

23. LIU AY, Zhang J, Anderson PL, Wagner T, et al
    Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.
    Clin Infect Dis. 2018 Oct 4. pii: 5115666. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
24. HOESLEY CJ, Chen BA, Anderson PL, Dezzutti CS, et al
    Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.
    Clin Infect Dis. 2018 Oct 4. pii: 5115615. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
25. CHEN BA, Zhang J, Gundacker HM, Hendrix CW, et al
    Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.
    Clin Infect Dis. 2018 Oct 4. pii: 5115671. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

26. CHEN J, Zhang R, Shen Y, Liu L, et al
    Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
    HIV Med. 2018 Oct 12. doi: 10.1111/hiv.12679.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

27. MAZHNAYA A, Marcus R, Bojko MJ, Zelenev A, et al
    Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    J Acquir Immune Defic Syndr. 2018;79:288-295.
    PubMed     Text format     Abstract available
    
    
28. LEE WK, Milloy MJS, Nosova E, Walsh J, et al
    Predictors of antiretroviral adherence self-efficacy among people living with HIV/AIDS in a Canadian setting.
    J Acquir Immune Defic Syndr. 2018 Oct 5. doi: 10.1097/QAI.0000000000001878.
    PubMed     Text format     Abstract available
    
    
29. WANG R, Shlipak MG, Ix JH, Brown TT, et al
    The Association of Fibroblast Growth Factor-23 (FGF-23) with Incident Frailty in HIV-Infected and -Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2018 Oct 1. doi: 10.1097/QAI.0000000000001868.
    PubMed     Text format     Abstract available
    
    
30. ROBERTSON MM, Penrose K, Irvine MK, Robbins RS, et al
    Impact of an HIV Care Coordination Program on Durable Viral Suppression.
    J Acquir Immune Defic Syndr. 2018 Oct 1. doi: 10.1097/QAI.0000000000001877.
    PubMed     Text format     Abstract available
    
    
31. MASSANELLA M, Karris MY, Perez-Santiago J, Yek C, et al
    Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV.
    J Acquir Immune Defic Syndr. 2018;79:399-406.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

32. DEL RIO-INIGUEZ I, Vazquez-Chavez E, Cuche C, Di Bartolo V, et al
    HIV-1 Nef Hijacks Lck and Rac1 Endosomal Traffic To Dually Modulate Signaling-Mediated and Actin Cytoskeleton-Mediated T Cell Functions.
    J Immunol. 2018 Oct 3. pii: jimmunol.1800372. doi: 10.4049/jimmunol.1800372.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

33. SZANIAWSKI MA, Spivak AM, Bosque A, Planelles V, et al
    Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages.
    J Infect Dis. 2018 Oct 8. pii: 5123692. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
34. DOMBROWSKI JC, Baeten JM
    It's Time to Make the Time to Viral Suppression After HIV Diagnosis a Metric of HIV Care Success.
    J Infect Dis. 2018 Oct 10. pii: 5116321. doi: 10.1093.
    PubMed     Text format    
    
    
35. XIA Q, Coeytaux K, Braunstein SL, Torian LV, et al
    Proposing a New Indicator for the National Human Immunodeficiency Virus/AIDS Strategy: Percentage of Newly Diagnosed Persons Achieving Viral Suppression Within 3 Months of Diagnosis.
    J Infect Dis. 2018 Oct 10. pii: 5116324. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
36. JAIMES-BERNAL C, Rallon N, Benito JM, Mohamed-Balghata MO, et al
    Knock-out IFNL4 gene variant is associated with protection from sexually transmitted HIV-1 infection.
    J Infect Dis. 2018 Oct 5. pii: 5115710. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
37. RICHARDS V
    Should we consider marijuana use in relation to physical activity and cognitive impairment in persons with HIV infection?
    J Infect Dis. 2018 Oct 5. pii: 5115716. doi: 10.1093.
    PubMed     Text format    
    
    
38. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Reply to Suthar et al.
    J Infect Dis. 2018 Oct 11. pii: 5126520. doi: 10.1093.
    PubMed     Text format    
    
    
39. SUTHAR AB, Coggin W, Raizes E
    Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS.
    J Infect Dis. 2018 Oct 11. pii: 5126519. doi: 10.1093.
    PubMed     Text format    
    
    
40. RODRIGUEZ-GALLEGO E, Tarancon-Diez L, Garcia F, Del Romero J, et al
    Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite Control.
    J Infect Dis. 2018 Oct 12. pii: 5127217. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

41. KINLOCH NN, Lee GQ, Carlson JM, Jin SW, et al
    Genotypic and Mechanistic Characterization of Subtype-specific HIV Adaptation to Host Cellular Immunity.
    J Virol. 2018 Oct 10. pii: JVI.01502-18. doi: 10.1128/JVI.01502.
    PubMed     Text format     Abstract available
    
    
42. HARGETT AA, Wei Q, Knoppova B, Hall S, et al
    Defining HIV-1 Envelope N-glycan Microdomains Through Site-specific Heterogeneity Profiles.
    J Virol. 2018 Oct 10. pii: JVI.01177-18. doi: 10.1128/JVI.01177.
    PubMed     Text format     Abstract available
    
    
43. HOANG TN, Harper JL, Pino MC, Wang H, et al
    Bone marrow-derived CD4(+) T cells are depleted in SIV-infected macaques and contribute to the size of the replication competent reservoir on ART.
    J Virol. 2018 Oct 10. pii: JVI.01344-18. doi: 10.1128/JVI.01344.
    PubMed     Text format     Abstract available
    
    
44. SOARE AY, Durham ND, Gopal R, Tweel B, et al
    P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1beta in a human tonsil explant model.
    J Virol. 2018 Oct 10. pii: JVI.01186-18. doi: 10.1128/JVI.01186.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

45. WEBSTER P
    PEPFAR at 15 years.
    Lancet. 2018;392:200.
    PubMed     Text format    
    
    
46. NAKKAZI E
    Changes to dolutegravir policy in several African countries.
    Lancet. 2018;392:199.
    PubMed     Text format    
    
    

    
    Lancet HIV

47. KARIM SSA
    Optimising the accuracy of HIV drug resistance assays.
    Lancet HIV. 2018 Sep 28. pii: S2352-3018(18)30211.
    PubMed     Text format    
    
    
48. INZAULE SC, Hamers RL, Noguera-Julian M, Casadella M, et al
    Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
    Lancet HIV. 2018 Sep 28. pii: S2352-3018(18)30177.
    PubMed     Text format     Abstract available
    
    
49. FINOCCHARIO-KESSLER S, Gautney B, Cheng A, Wexler C, et al
    Evaluation of the HIV Infant Tracking System (HITSystem) to optimise quality and efficiency of early infant diagnosis: a cluster-randomised trial in Kenya.
    Lancet HIV. 2018 Oct 8. pii: S2352-3018(18)30245.
    PubMed     Text format     Abstract available
    
    
50. LESTER RT
    Digital health to support early infant diagnosis of HIV.
    Lancet HIV. 2018 Oct 8. pii: S2352-3018(18)30266.
    PubMed     Text format    
    
    
51. KAVANAGH MM, Baral SD, Milanga M, Sugarman J, et al
    Biometrics and public health surveillance in criminalised and key populations: policy, ethics, and human rights considerations.
    Lancet HIV. 2018 Oct 5. pii: S2352-3018(18)30243.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Infect Dis

52. KISSINGER P, Muzny CA, Mena LA, Lillis RA, et al
    Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Lancet Infect Dis. 2018 Oct 5. pii: S1473-3099(18)30423.
    PubMed     Text format     Abstract available
    
    
53. HUGHES G, Fifer H
    Point-of-care tests for chlamydia and gonorrhoea in Indigenous communities.
    Lancet Infect Dis. 2018;18:1054-1055.
    PubMed     Text format    
    
    

    
    MMWR Morb Mortal Wkly Rep

54. LUNA-GIERKE RE, Shouse RL, Luo Q, Frazier E, et al
    Differences in Characteristics and Clinical Outcomes Among Hispanic/Latino Men and Women Receiving HIV Medical Care - United States, 2013-2014.
    MMWR Morb Mortal Wkly Rep. 2018;67:1109-1114.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

55. MUFTUOGLU M, Olson A, Marin D, Ahmed S, et al
    Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    N Engl J Med. 2018;379:1443-1451.
    PubMed     Text format     Abstract available
    
    
56. ZASH R, Makhema J, Shapiro RL
    Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
    N Engl J Med. 2018;379:979-981.
    PubMed     Text format    
    
    

    
    Nature

57. BORDUCCHI EN, Liu J, Nkolola JP, Cadena AM, et al
    Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.
    Nature. 2018 Oct 3. pii: 10.1038/s41586-018-0600.
    PubMed     Text format     Abstract available
    
    

    
    Pediatr Infect Dis J

58. MADRID L, Maculuve SA, Vilajeliu A, Saez E, et al
    Maternal Carriage of Group B Streptococcus and Escherichia coli in a District Hospital in Mozambique.
    Pediatr Infect Dis J. 2018;37:1145-1153.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

59. LOELIGER KB, Meyer JP, Desai MM, Ciarleglio MM, et al
    Retention in HIV care during the 3 years following release from incarceration: A cohort study.
    PLoS Med. 2018;15:e1002667.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

60. TEMIYE EO, Adeniyi OF, Fajolu IB, Ogbenna AA, et al
    Human immunodeficiency virus status in malnourished children seen at Lagos.
    PLoS One. 2018;13:e0200435.
    PubMed     Text format     Abstract available
    
    
61. SOSA-JURADO F, Melendez-Mena D, Rosas-Murrieta NH, Guzman-Flores B, et al
    Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients.
    PLoS One. 2018;13:e0205356.
    PubMed     Text format     Abstract available
    
    
62. LODIONGO DK, K Bior B, W Dumo G, S Katoro J, et al
    Field evaluation of SD BIOLINE HIV/Syphilis Duo assay among pregnant women attending routine antenatal care in Juba, South Sudan.
    PLoS One. 2018;13:e0205383.
    PubMed     Text format     Abstract available
    
    
63. HIRASEN K, Berhanu R, Evans D, Rosen S, et al
    High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
    PLoS One. 2018;13:e0205463.
    PubMed     Text format     Abstract available
    
    
64. JUANBELTZ R, Martinez-Baz I, San Miguel R, Goni-Esarte S, et al
    Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.
    PLoS One. 2018;13:e0205277.
    PubMed     Text format     Abstract available
    
    
65. VAN GRIENSVEN F, Mock PA, Benjarattanaporn P, Premsri N, et al
    Estimating recent HIV incidence among young men who have sex with men: Reinvigorating, validating and implementing Osmond's algorithm for behavioral imputation.
    PLoS One. 2018;13:e0204793.
    PubMed     Text format     Abstract available
    
    
66. PRICE CA, Green-Thompson L, Mammen VG, Madhi SA, et al
    Knowledge gaps among South African healthcare providers regarding the prevention of neonatal group B streptococcal disease.
    PLoS One. 2018;13:e0205157.
    PubMed     Text format     Abstract available
    
    
67. NEUMANN MS, Plant A, Margolis AD, Borkowf CB, et al
    Effects of a brief video intervention on treatment initiation and adherence among patients attending human immunodeficiency virus treatment clinics.
    PLoS One. 2018;13:e0204599.
    PubMed     Text format     Abstract available
    
    
68. QIN S, Clausen E, Nouraie SM, Kingsley L, et al
    Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation.
    PLoS One. 2018;13:e0205065.
    PubMed     Text format     Abstract available
    
    
69. ARIMIDE DA, Abebe A, Kebede Y, Adugna F, et al
    HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013.
    PLoS One. 2018;13:e0205446.
    PubMed     Text format     Abstract available
    
    
70. MAGOHE A, Mackenzie T, Kimario J, Lukmanji Z, et al
    Pre- and post-natal macronutrient supplementation for HIV-positive women in Tanzania: Effects on infant birth weight and HIV transmission.
    PLoS One. 2018;13:e0201038.
    PubMed     Text format     Abstract available
    
    
71. PATTEN G, Bernheimer J, Fairlie L, Rabie H, et al
    Lamivudine monotherapy as a holding regimen for HIV-positive children.
    PLoS One. 2018;13:e0205455.
    PubMed     Text format     Abstract available
    
    
72. COYER L, van Bilsen W, Bil J, Davidovich U, et al
    Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use.
    PLoS One. 2018;13:e0205663.
    PubMed     Text format     Abstract available
    
    
73. JUDD A, Foster C, Thompson LC, Sturgeon K, et al
    Sexual health of young people with perinatal HIV and HIV negative young people in England.
    PLoS One. 2018;13:e0205597.
    PubMed     Text format     Abstract available
    
    
74. HURUY K, Mulu A, Liebert UG, Melanie M, et al
    HIV-1C proviral DNA for detection of drug resistance mutations.
    PLoS One. 2018;13:e0205119.
    PubMed     Text format     Abstract available
    
    
75. LINCE-DEROCHE N, van Rensburg C, Roseleur J, Sanusi B, et al
    Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.
    PLoS One. 2018;13:e0203921.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

76. RAWLE DJ, Harrich D
    Toward the "unravelling" of HIV: Host cell factors involved in HIV-1 core uncoating.
    PLoS Pathog. 2018;14:e1007270.
    PubMed     Text format    
    
    
77. CAO Y, Cartwright EK, Silvestri G, Perelson AS, et al
    CD8+ lymphocyte control of SIV infection during antiretroviral therapy.
    PLoS Pathog. 2018;14:e1007350.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

78. SHI G, Ozog S, Torbett BE, Compton AA, et al
    mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
    Proc Natl Acad Sci U S A. 2018 Oct 9. pii: 1811892115.
    PubMed     Text format     Abstract available
    
    

    
    Science

79. COHEN J
    The pill exchange.
    Science. 2018;360:1174.
    PubMed     Text format    
    
    
80. COHEN J
    The loyal opposition.
    Science. 2018;360:1175.
    PubMed     Text format    
    
    
81. COHEN J
    Status symbol.
    Science. 2018;360:1171.
    PubMed     Text format    
    
    
82. COHEN J
    Dark nights, bright stars.
    Science. 2018;360:1170-1175.
    PubMed     Text format    
    
    
83. COHEN J
    The Sunshine State's dark cloud.
    Science. 2018;360:1176-1179.
    PubMed     Text format    
    
    
84. COHEN J
    Poster couple.
    Science. 2018;360:1172.
    PubMed     Text format    
    
    

    
    Vaccine

85. MUGO NR, Eckert L, Magaret AS, Cheng A, et al
    Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31328.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: